AMPK ↔ Sirt1: From a signaling network to a combination drug

Metabolism: Clinical and Experimental

Volumn 65, Issue 11, 2016, Pages 1692-1694

  Dagon, Yossi ^a   Mantzoros, Christos S ^a   Kim, Young Bum ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEUCINE; METFORMIN; SIRTUIN 1;

ALPHA CHAIN; AUTOPHAGY; CELL ENERGY; DEACETYLATION; DRUG TOLERABILITY; EDITORIAL; ENERGY BALANCE; ENZYME SUBSTRATE COMPLEX; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; INSULIN SENSITIVITY; LIPID METABOLISM; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AMP-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 84991508696     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2016.07.014     Document Type: Editorial

References (23)

1. [1] Assan, R, Heuclin, C, Girard, JR, LeMaire, F, Attali, JR, Phenformin-induced lactic acidosis in diabetic patients. Diabetes 24 (1975), 791–800.
2. [2] Watkins, PB, Whitcomb, RW, Hepatic dysfunction associated with troglitazone. N Engl J Med 338 (1988), 916–917.
3. [3] Watkins, PB, Whitcomb, RW, Cardiovascular risk and the thiazolidinediones: déjà vu all over again?. JAMA 298 (2007), 1216–1218.
4. [4] Kemp, JA, Shim, MS, Heo, CY, Kwon, YJ, “combo” nanomedicine: co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy. Adv Drug Deliv Rev 98 (2016), 3–18.
5. [5] Banerjee, J, Bruckbauer, A, Zemel, MB, Activation of the AMPK/Sirt1 pathway by a leucine-metformin combination increases insulin sensitivity in skeletal muscle, and stimulates glucose and lipid metabolism and increases lifespan in Canaerhobditis elegans. Metabolism, 2016 (in press).
6. [6] Fu, L, Bruckbauer, A, Li, F, Cao, Q, Cui, X, Wu, R, et al. Leucine amplifies the effects of metformin on insulin sensitivity and glycemic control in diet-induced obese mice. Metabolism 64 (2015), 845–856.
7. [7] Shaw, RJ, Lamia, KA, Vasquez, D, Koo, SH, Bardeesy, N, Depinho, RA, et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 301 (2005), 1642–1646.
8. [8] Kahn, BB, Alquier, T, Carling, D, Hardie, DG, AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab 1 (2005), 15–25.
9. [9] Hardie, DG, Ross, FA, Hawley, SA, AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 13 (2012), 251–262.
10. [10] Pimentel, GD, Ropelle, ER, Rocha, GZ, Carvalheira, JB, The role of neuronal AMPK as a mediator of nutritional regulation of food intake and energy homeostasis. Metabolism 62 (2013), 171–178.
11. [11] Nakano, M, Hamada, T, Hayashi, T, Yonemitsu, S, Miyamoto, L, Toyoda, T, et al. α2 Isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle. Metabolism 55 (2006), 300–308.
12. [12] Weikel, KA, Ruderman, NB, Cacicedo, JM, Unraveling the actions of AMP-activated protein kinase in metabolic diseases: systemic to molecular insights. Metabolism 65 (2016), 634–645.
13. [13] Lan, F, Cacicedo, JM, Ruderman, N, Ido, Y, SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1 possible role in AMP-activated protein kinase activation. J Biol Chem 283 (2008), 27628–27635.
14. [14] Cantó, C, Gerhart-Hines, Z, Feige, JN, Lagouge, M, Noriega, L, Milne, JC, et al. AMPK regulates energy expenditure by modulating NAD + metabolism and SIRT1 activity. Nature 458 (2009), 1056–1060.
15. [15] Houtkooper, RH, Pirinen, E, Auwerx, J, Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol 13 (2012), 225–238.
16. [16] Ghosh, HS, Reizis, B, Robbins, PD, SIRT1 associates with eIF2-alpha and regulates the cellular stress response. Sci Rep, 1, 2011, 150.
17. [17] Dagon, Y, Avraham, Y, Berry, EM, AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes. Biochem Biophys Res Commun 340 (2006), 43–47.
18. [18] Lee, DH, Huang, H, Choi, K, Mantzoros, C, Kim, YB, Selective PPARγ modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice. Am J Physiol Endocrinol Metab 302 (2012), 552–560.
19. [19] Dagon, Y, Avraham, Y, Magen, I, Gertler, A, Ben-Hur, T, Berry, M, Nutritional status, cognition, and survival: a new role for leptin and AMP kinase. J Biol Chem 280 (2005), 42142–42148.
20. [20] Salminen, A, Kaarniranta, K, AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Res Rev 11 (2012), 230–241.
21. [21] Dagon, Y, Hur, E, Zheng, B, Wellenstein, K, Cantley, LC, Kahn, BB, p70S6 kinase phosphorylates AMPK on serine 491 to mediate leptin's effect on food intake. Cell Metab 16 (2012), 104–112.
22. [22] Dagon, Y, Mantzoros, C, Kim, YB, Exercising insulin sensitivity: AMPK turns on autophagy!. Metabolism 64 (2015), 655–657.
23. [23] Liu, X, Niu, Y, Yuan, H, Huang, J, Fu, L, AMPK binds to Sestrins and mediates the effect of exercise to increase insulin-sensitivity through autophagy. Metabolism 64 (2015), 658–665.